Five patents currently held, every record listed here
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2035. from the record
Of the 3 now held by other companies, 2 name Fabri Form Holdings LLC as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2035
Next term end
5
Patent families
When these terms end
Each bar runs from grant to computed term end. 2015 to 2042.20212027203320392042
4 pending applications: term is not computable until grant.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends May 2035 · High confidence
Also notable
Ends Oct 2036 · High confidence
Also notable
Ends Feb 2036 · Medium confidence
Dynamic Cache Partitioning Apparatus and Method
US 9,645,933
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2035.
Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors
US 10,709,702
Granted 2020. Computed term ends 2036.
Ophthalmic Compositions of Rifamycins and Uses Thereof
US 11,850,213
Granted 2023. Computed term ends 2036.
Formerly held, still cited
Notable
Ends May 2033 · High confidence
Renewed at every maintenance window since the 2015 grant; no more fees are due before its term ends in 2033.
now held by Advanced Micro Devices, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Jun 26 to 30, 2027 · next Jun 26
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 2 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors | 1 in force | to Oct 2036 |
| Ophthalmic Compositions of Rifamycins and Uses Thereof | 1 in force | to Feb 2036 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,645,933 | Dynamic Cache Partitioning Apparatus and Method held by AMD Products (China) Co., Ltd. In force · High confidence | In force | High confidence | |
| US 11,850,213 | Ophthalmic Compositions of Rifamycins and Uses Thereof held by AMD Therapeutics LLC In force · Medium confidence | In force | Medium confidence | |
| US 10,709,702 | Treatment of Skin Disorders by Topical Administration of VEGF Inhibitors held by AMD Therapeutics LLC In force · High confidence | In force | High confidence | |
| US 10,520,200 | Multi-Fuel Grill Apparatus held by AMD Direct, Inc. In force · High confidence | In force | High confidence | |
| US 10,754,149 | Efficient Radial Lens Shading Correction held by AMD (Shanghai) Co., Ltd. In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 3 patents in force now held by others · 59 patents ended · 4 applications pending · 8 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.